TRIAL IN PROGRESS: T-RREX - A PIVOTAL PHASE 2 STUDY OF WU-CART-007 (SOFI-CEL), CD7-DIRECTED ALLOGENEIC CAR-T CELL THERAPY, IN PATIENTS WITH R/R T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
EHA Library, Elias Jabbour,
4209153
EFFICACY AND SAFETY OF INOTUZUMAB OZOGAMICIN IN ADULT CHINESE PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: LONG-TERM RESULTS OF AN OPEN-LABEL, MULTI-CENTER, PHASE 4 TRIAL.
EHA Library, Depei Wu,
4209164
COMBINATION OF CD19-TARGETED CAR-T CELL THERAPY WITH ALLO-HSCT IN THE TREATMENT OF RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. A SINGLE CENTER, PROSPECTIVE, SINGLE-ARM STUDY
EHA Library, Guopan Yu,
4209132
EFFICACY AND SAFETY OF THE FLUMATINIB, VENETOCLAX, VINCRISTINE, AND PREDNISONE (FVVP) REGIMEN IN NEWLY DIAGNOSED ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Weimin Wang,
4209135
SECURED INPATIENT BLINATUMOMAB PATHWAY: A SINGLE-CENTER EXPERIENCE (PROPHYLAXIS, IMMUNOGLOBULIN SUPPLEMENTATION, DEDICATED VASCULAR ACCESS, CRS/ICANS ALGORITHMS)
EHA Library, sihem kebaili,
4209197